MolNFT v1 · #88499 · protein
Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor
4CWT · Heat shock protein HSP 90-alpha: “Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor”. X-ray diffraction, 1 ligand (IK9), 1 pocket (best druggability 0.70). MolNFT v1 #88499 on GenesisL1: 3D…
- PDB
- 4CWT
- Type
- protein
- Length
- 209 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Heat shock protein HSP 90-alpha
- UniProt
- P07900
- Ligands
- IK9
- Pockets
- 1 · best druggability 0.70
Structure
x-ray diffraction · 1 distinct chain · 45% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Heat shock protein HSP 90-alpha | protein | 209 | 45% helix, 22% strand | P07900 |
Ligands and binding sites
- IK9 · 2-{[(2Z)-5-(1,3-benzodioxol-5-ylmethyl)-8-fluoro-2-imino-2,3-dihydro[1,2,4]triazolo[1,5-c]quinazolin-10-yl]amino}ethanol · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 298 | 0.70 | 0.84 | 37 | IK9 |
Compared structures
- 4CWT · Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P07900
- Elsewhere: RCSB PDB 4CWT · PDBe 4CWT · UniProt P07900
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.